Immunome appoints Purnanand Sarma as president and CEO
Mr. Sarma brings more than 25 years of industry experience with a proven track record in drug development, fund raising, and growing companies.
Prior to joining Immunome, Mr. Sarma was the President and CEO of Taris Biomedical.
Prior to TARIS, he served in several leadership roles at Cephalon Corporation, which was acquired by Teva Pharmaceutical Industries; Nektar Therapeutics; and SmithKline Beecham, now Glaxo SmithKline.
Mr. Sarma earned his PhD in Pharmaceutics from the University of Minnesota and B. Pharm from Andhra University, Visakhapatnam, India. ■